United Kingdom· GB-APID-37633411000001104
Eklira 322micrograms/dose Genuair
A medicinal product containing aclidinium bromide, registered in United Kingdom by Pilsco Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Aclidinium bromide
- Manufacturer
- Pilsco Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05060669871835
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aclidinium bromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRETARIS GENUAIRCovis Pharma Europe B.V., Amsterdam
- BelgiumBretaris Genuair 322 µgCovis Pharma Europe
- FinlandBretaris GenuairCOVIS PHARMA EUROPE B.V.
- IrelandBretaris Genuair 322 micrograms inhalation powderCovis Pharma Europe B.V.
- SwitzerlandEklira Genuair
- SpainBRETARIS GENUAIRCovis Pharma Europe B.V.
- NetherlandsBretaris Genuair 322 microgram inhalatiepoederCovis Pharma Europe B.V.
- PolandBretaris GenuairCovis Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bretaris Genuair, Eklira Genuair
- Liechtenstein · Bretaris Genuair, Eklira Genuair
- Norway · Bretaris Genuair, Eklira Genuair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1eb968d9-ce40-4a7f-a8d7-1954dd7ecb5e GET /v1/drugs/1eb968d9-ce40-4a7f-a8d7-1954dd7ecb5e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37633411000001104",
"desc": "Eklira 322micrograms/dose Genuair (Pilsco Ltd)",
"form": "Inhalation powder",
"vpid": "38893611000001108",
"source": "dmd",
"vtm_id": "21021511000001105",
"strength": "375 microgram",
"substance": "Aclidinium bromide",
"ingredient": "Aclidinium bromide",
"supplier_code": "37621811000001104"
}See everything about aclidinium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.